4//SEC Filing
THANGARAJ IMMANUEL 4
Accession 0001104659-22-003594
CIK 0000786947other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 4:10 PM ET
Size
11.5 KB
Accession
0001104659-22-003594
Insider Transaction Report
Form 4
THANGARAJ IMMANUEL
Director
Transactions
- Exercise/Conversion
Common Stock
2022-01-03+66,666→ 330,981 total - Exercise/Conversion
Restricted Stock Units (2021 Plan)
2022-01-03−66,666→ 0 total→ Common Stock (66,666 underlying) - Award
Restricted Stock Units (2021 Plan)
2022-01-03−66,666→ 66,666 total→ Common Stock (66,666 underlying)
Holdings
- 1,956,396(indirect: By Essex Woodlands Health Venture Fund V, L.P.)
Common Stock
Footnotes (8)
- [F1]Represents exchange of restricted stock units.
- [F2]Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock
- [F3]Does not include Restricted Stock Units.
- [F4]1 - for - 1
- [F5]66,666 Restricted Stock Units were granted on May 25, 2021. 50% of Restricted Stock Units vested on the last day of June 2021, while 25% of Restricted Stock Units vested on the last day of September 2021 and December 2021. Restricted Stock Units are being exchanged on a one for one basis for common stock, in each case upon payment of par value.
- [F6]N/A
- [F7]66,666 Restricted Stock Units were granted on January 3, 2022. 25% of Restricted Stock Units vest on the last day of each of March, June, September and December 2022, subject to immediate vesting in the event of a change of control and certain other events. Reporting Person may elect to exchange up to 40% of Restricted Stock Units for cash and the remaining Restricted Stock Units will be exchanged on a one for one basis for common stock, in each case upon payment of, or deduction of par value. Distributions in respect of vested Restricted Stock Units will be made on the first business day of January 2023, or earlier upon a change of control.
- [F8]The reporting person is a managing director of the general partner of Essex Woodlands Health Ventures Fund V, L.P. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
ACURA PHARMACEUTICALS, INC
CIK 0000786947
Entity typeother
Related Parties
1- filerCIK 0001213308
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 4:10 PM ET
- Size
- 11.5 KB